|
1
|
Deng H, Liu R, Ellmeier W, Choe S, Unutmaz
D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, et al:
Identification of a major co-receptor for primary isolates of
HIV-1. Nature. 381:661–666. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu R, Paxton WA, Choe S, Ceradini D,
Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR,
et al: Homozygous defect in HIV-1 coreceptor accounts for
resistance of some multiply-exposed individuals to HIV-1 infection.
Cell. 86:367–377. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fätkenheuer G, Pozniak AL, Johnson MA,
Plettenberg A, Staszewski S, Hoepelman AI, Saag MS, Goebel FD,
Rockstroh JK, Dezube BJ, et al: Efficacy of short-term monotherapy
with maraviroc, a new CCR5 antagonist, in patients infected with
HIV-1. Nat Med. 11:1170–1172. 2015. View
Article : Google Scholar
|
|
4
|
Hütter G, Nowak D, Mossner M, Ganepola S,
Müßig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, et
al: Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell
transplantation. N Engl J Med. 360:692–698. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allers K, Hütter G, Hofmann J,
Loddenkemper C, Rieger K, Thiel E and Schneider T: Evidence for the
cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Blood. 117:2791–2799. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DiGiusto DL, Krishnan A, Li L, Li H, Li S,
Rao A, Mi S, Yam P, Stinson S, Kalos M, et al: RNA-based gene
therapy for HIV with lentiviral vector-modified CD34(+) cells in
patients undergoing transplantation for AIDS-related lymphoma. Sci
Transl Med. 2:362010. View Article : Google Scholar
|
|
7
|
Tebas P, Stein D, Tang WW, Frank I, Wang
SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, et al: Gene
editing of CCR5 in autologous CD4 T cells of persons infected with
HIV. N Engl J Med. 370:901–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mussolino C, Morbitzer R, Lütge F,
Dannemann N, Lahaye T and Cathomen T: A novel TALE nuclease
scaffold enables high genome editing activity in combination with
low toxicity. Nucleic Acids Res. 39:9283–9293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holkers M, Maggio I, Liu J, Janssen JM,
Miselli F, Mussolino C, Recchia A, Cathomen T and Gonçalves MA:
Differential integrity of TALE nuclease genes following adenoviral
and lentiviral vector gene transfer into human cells. Nucleic Acids
Res. 41:e632014. View Article : Google Scholar
|
|
10
|
Mock U, Machowicz R, Hauber I, Horn S,
Abramowski P, Berdien B, Hauber J and Fehse B: mRNA transfection of
a novel TAL effector nuclease (TALEN) facilitates efficient
knockout of HIV co-receptor CCR5. Nucleic Acids Res. 43:5560–5571.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang W, Ye C, Liu J, Zhang D, Kimata JT
and Zhou P: CCR5 gene disruption via lentiviral vectors expressing
Cas9 and single guided RNA renders cells resistant to HIV-1
infection. PLoS One. 9:e1159872014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou P, Chen S, Wang S, Yu X, Chen Y, Jiang
M, Zhuang K, Ho W, Hou W, Huang J and Guo D: Genome editing of
CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.
Sci Rep. 5:155772015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perez EE, Wang J, Miller JC, Jouvenot Y,
Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, et al:
Establishment of HIV-1 resistance in CD4+ T cells by genome
editing using zinc-finger nucleases. Nat Biotechnol. 26:808–816.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Krymskaya L, Wang J, Henley J, Rao
A, Cao LF, Tran CA, Torres-Coronado M, Gardner A, Gonzalez N, et
al: Genomic editing of the HIV-1 coreceptor CCR5 in adult
hematopoietic stem and progenitor cells using zinc finger
nucleases. Mol Ther. 21:1259–1269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holt N, Wang J, Kim K, Friedman G, Wang X,
Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC and Cannon PM:
Human hematopoietic stem/progenitor cells modified by zinc-finger
nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol.
28:839–847. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maier DA, Brennan AL, Jiang S,
Binder-Scholl GK, Lee G, Plesa G, Zheng Z, Cotte J, Carpenito C,
Wood T, et al: Efficient clinical scale gene modification via zinc
finger nuclease-targeted disruption of the HIV co-receptor CCR5.
Hum Gene Ther. 24:245–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mandal PK, Ferreira LM, Collins R,
Meissner TB, Boutwell CL, Friesen M, Vrbanac V, Garrison BS,
Stortchevoi A, Bryder D, et al: Efficient ablation of genes in
human hematopoietic stem and effector cells using CRISPR/Cas9. Cell
Stem Cell. 15:643–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carrington M, Kissner T, Gerrard B, Ivanov
S, O'Brien SJ and Dean M: Novel alleles of the chemokine-receptor
gene CCR5. Am J Hum Genet. 61:1261–1267. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berger EA, Murphy PM and Farber JM:
Chemokine receptors as HIV-1 coreceptors: roles in viral entry,
tropism, and disease. Annu Rev Immunol. 17:657–700. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martinson JJ, Chapman NH, Rees DC, Liu YT
and Clegg JB: Global distribution of the CCR5 gene 32-basepair
deletion. Nat Genet. 16:100–103. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye L, Wang J, Beyer AI, Teque F, Cradick
TJ, Qi Z, Chang JC, Bao G, Muench MO, Yu J, et al: Seamless
modification of wild-type induced pluripotent stem cells to the
natural CCR5Δ32 mutation confers resistance to HIV infection. Proc
Natl Acad of Sci USA. 111:9591–9596. 2014. View Article : Google Scholar
|
|
22
|
Goudsmit J, Lange JM, Paul DA and Dawson
GJ: Antigenemia and antibody titers to core and envelope antigens
in AIDS, AIDS-related complex and subclinical human
immunodeficiency virus infection. J Infect Dis. 155:558–560. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilen CB, Wang J, Tilton JC, Miller JC,
Kim KA, Rebar EJ, Sherrill-Mix SA, Patro SC, Secreto AJ, Jordan AP,
et al: Engineering HIV-resistant human CD4+ T cells with
CXCR4-specific zinc-finger nucleases. PLoS Pathog. 7:e10020202011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song H, Chung SK and Xu Y: Modeling
disease in human ESCs using an efficient BAC-based homologous
recombination system. Cell Stem Cell. 6:80–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nassif N, Penney J, Pal S, Engels W and
Gloor G: Efficient copying of nonhomologous sequences from ectopic
sites via P-element-induced gap repair. Mol Cell Biol.
14:1613–1625. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Symington LS: Role of RAD52 epistasis
group genes in homologous recombination and double-strand break
repair. Microbiol Mol Biol Rev. 66:630–670. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu Y, Foden JA, Khayter C, Maeder ML,
Sander JD, Reyon D and Joung JK: High-frequency off-target
mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat
Biotechnol. 31:822–826. 2013. View Article : Google Scholar : PubMed/NCBI
|
